Clinical Trials in Salt Lake City

Showing 2381-2400 of 16,694 trials

Neoadjuvant Ipilimumab/Nivolumab for Patients With Recurrent, High Risk, Resectable Melanoma

NCT06365619

The goal of this clinical trial is to study the impact of Neoadjuvant ipilimumab and nivolumab for melanoma patients that had recurrence during or after adjuvant anti-PD-1 therapy. Participants will receive 2 cycles of treatment prior to their standard of care surgery. After surgery participants will receive standard of care adjuvant therapy and be followed for response.

Melanoma

University of Utah25 participantsStarted Feb 2026

Salt Lake City, Utah, United States

COMPLETEDPhase 3< 1 mile

Sorafenib Tosylate With or Without Stereotactic Body Radiation Therapy in Treating Patients With Liver Cancer

NCT01730937

This randomized phase III trial studies sorafenib tosylate and stereotactic body radiation therapy to see how well they work compared to sorafenib tosylate alone in treating patients with liver cancer. Sorafenib tosylate may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. Stereotactic body radiation therapy may be able to send the radiation dose directly to the tumor and cause less damage to normal tissue. Giving sorafenib tosylate together with stereotactic body radiation therapy may kill more tumor cells.

Adult Primary Hepatocellular CarcinomaAdvanced Adult Primary Liver CancerRecurrent Adult Primary Liver Cancer

Radiation Therapy Oncology Group193 participantsStarted Apr 2013

Berkeley, California, United States • Los Angeles, California, United States • San Francisco, California, United States +48 more locations

Neoadjuvant Ipilimumab/Nivolumab for Patients With Recurrent, High Risk, Resectable Melanoma

Sorafenib Tosylate With or Without Stereotactic Body Radiation Therapy in Treating Patients With Liver Cancer

Find Trials by Condition in Salt Lake City

A 12-week Study to Assess the Efficacy and Safety of Budesonide and Formoterol Fumarate Metered Dose Inhaler Relative to Budesonide Metered Dose Inhaler in Participants With Inadequately Controlled Asthma (LITHOS)

A Study to Evaluate the Efficacy and Safety of ABC008 for Inclusion Body Myositis

Assessing an Oral EGFR Inhibitor, Sunvozertinib in Patients Who Have Advanced Non-small Cell Lung Cancer With EGFR or HER2 Mutation (WU-KONG1)

Phase III Study Assessing the Efficacy and Safety of Pegcetacoplan in Patients With C3 Glomerulopathy or Immune-Complex Membranoproliferative Glomerulonephritis

A Study of a Novel Iron-based Phosphate Binder AP301 in Patients With Hyperphosphatemia in the U.S. and China

Safety and Performance Using Legion™ CR Oxinium and CoCr Femoral Implants Combined With Legion™/Genesis™ II XLPE High Flex Tibial Inserts

Study to Compare Efficacy, Safety, and Immunogenicity of LUBT010 (Proposed Ranibizumab Biosimilar) and Lucentis® in Patients With Neovascular AMD

A Study to Learn About the Safety of Litifilimab (BIIB059) Injections and Whether They Can Improve Symptoms of Adult Participants Who Have Systemic Lupus Erythematosus

Evaluation of Revumenib in Participants With Colorectal Cancer and Other Solid Tumors

Clinical Study of the Treovance Stent-Graft for Patients With Abdominal Aortic Aneurysms

Home OCT-Guided Treatment Versus Treat and Extend for the Management of Neovascular AMD

Pacritinib in Relapsed/Refractory T-cell Lymphoproliferative Neoplasms

R-3750 in Patients With Mild to Moderate Ulcerative Colitis

A Study of HMPL-306 in Advanced Hematological Malignancies With mIDH

Multicenter Trial of ECMO in Children With Severe Cardiac Failure Using the Cardiohelp System

TACE With or Without SBRT as Bridging Therapy for Pre-transplant HCC Patients

A Study of PHN-010 in Patients With Advanced Solid Tumors

A Study With CIT-013 in HS Patients